Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 13.75
0.00 (0.00%)
Jun 17, 2026, 5:06 PM GMT
Creo Medical Group Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5.3 | -28.7 | -21.7 | -26.9 | -24.6 |
Depreciation & Amortization | 0.9 | 1.3 | 1.7 | 2.9 | 2.41 |
Other Amortization | 0.1 | 0.2 | - | 0.2 | 0.15 |
Asset Writedown & Restructuring Costs | - | 1.4 | - | - | - |
Loss (Gain) on Equity Investments | -1.7 | - | - | - | - |
Stock-Based Compensation | 1.4 | 1.5 | 1.2 | 1.4 | 2.56 |
Other Operating Activities | -22.6 | 1.6 | -1.1 | 0.2 | -2.38 |
Change in Accounts Receivable | -3.5 | -1 | -1.4 | -1.6 | -3.17 |
Change in Inventory | 0.2 | 0.7 | -0.4 | -0.3 | -2.97 |
Change in Accounts Payable | 1 | 0.2 | -3.7 | -0.8 | 1.98 |
Operating Cash Flow | -19.1 | -22.2 | -21.6 | -24.9 | -26.01 |
Capital Expenditures | - | -0.3 | -1.2 | -3.2 | -5.98 |
Cash Acquisitions | - | - | -2.4 | -2.8 | -1.75 |
Divestitures | 20.3 | - | - | - | - |
Sale (Purchase) of Intangibles | -0.9 | -0.1 | -0.4 | -0.1 | -0.15 |
Investment in Securities | - | 15.5 | -15 | - | - |
Other Investing Activities | 0.5 | 0.2 | 0.7 | 0.1 | 0.03 |
Investing Cash Flow | 19.9 | 15.3 | -18.3 | -6 | -7.84 |
Long-Term Debt Issued | - | 6.4 | 0.2 | 2.8 | 0.14 |
Total Debt Issued | - | 6.4 | 0.2 | 2.8 | 0.14 |
Long-Term Debt Repaid | -0.6 | -1.3 | -2.1 | -2.4 | -2.36 |
Total Debt Repaid | -0.6 | -1.3 | -2.1 | -2.4 | -2.36 |
Net Debt Issued (Repaid) | -0.6 | 5.1 | -1.9 | 0.4 | -2.22 |
Issuance of Common Stock | - | 12.1 | 33.7 | - | 36.39 |
Other Financing Activities | -0.1 | -1 | -2 | - | -2.18 |
Financing Cash Flow | -0.7 | 16.2 | 29.8 | 0.4 | 31.99 |
Foreign Exchange Rate Adjustments | - | - | - | 0.1 | 0.3 |
Miscellaneous Cash Flow Adjustments | - | -3.6 | - | - | - |
Net Cash Flow | 0.1 | 5.7 | -10.1 | -30.4 | -1.56 |
Free Cash Flow | -19.1 | -22.5 | -22.8 | -28.1 | -31.99 |
Free Cash Flow Margin | -318.33% | -562.50% | -570.00% | -103.31% | -127.13% |
Free Cash Flow Per Share | -0.05 | -0.06 | -0.07 | -0.15 | -0.20 |
Cash Interest Paid | 0.4 | 0.7 | 0.4 | 0.3 | 0.46 |
Cash Income Tax Paid | -2.1 | -2.4 | -4.5 | -4.3 | -3.4 |
Levered Free Cash Flow | 12.75 | -31.96 | -19.13 | -23.64 | -20.93 |
Unlevered Free Cash Flow | 12.94 | -31.71 | -19 | -23.51 | -20.8 |
Change in Working Capital | -2.3 | -0.1 | -5.5 | -2.7 | -4.16 |